Feature | October 23, 2013

Developing World Faces Breast Cancer Surge, Study Suggests

Consumer awareness and cultural barriers surrounding screening putting lives at risk

mammography systems women's health ge healthcare
October 23, 2013 — Rising breast cancer incidence and mortality represent a significant and growing threat for the developing world, according to a new global study commissioned by GE Healthcare.
 
“Breast cancer is on the rise across developing nations mainly due to the increase in life expectancy and lifestyle changes such as women having fewer children, as well as hormonal intervention such as post-menopausal hormonal therapy,” said Bengt Jönsson, professor in health economics, Stockholm School of Economics and report co-author with Nils Wilking, M.D., Ph.D. “In these regions, mortality rates are compounded by the later stage at which the disease is diagnosed, as well as limited access to treatment, presenting a ‘ticking time bomb,’ which health systems and policymakers in these countries need to work hard to defuse.”?
 
Need for better consumer education
The report on “the prevention, early detection and economic burden of breast cancer” suggests that consumer understanding about breast cancer and screening methods is putting lives at risk in the developing world. For example, a recent survey[1] in Mexico City indicated many women feel uncomfortable or worried about having a mammogram.
 
“It is of great concern that women in newly industrialized countries are reluctant to get checked out until it is too late,” said Claire Goodliffe, global oncology director, GE Healthcare. “This is why GE is working with a number of governments and health ministries in these regions to expand access to screening and improve consumer awareness. Some of these initiatives are making excellent progress.”
 
Years of healthy life lost
The study draws some interesting conclusions about the impact of breast cancer on sufferers’ lives. According to the most recent published data, 15 million years of “healthy life” were lost worldwide in 2008 due to women dying early or being ill with the disease. “Healthy life lost” is defined by years lost due to premature death and being incapacitated by the effects of breast cancer. Women in Africa, China and the United States lost the most years of healthy life. Furthermore, of the 15 million years lost globally, more than three times as many years were lost due to dying than being ill with the disease. For women in Africa, Russia, Mexico, Turkey and Saudi Arabia, the number of healthy years lost due to death were up to seven times greater than elsewhere in the world.
 
“The report findings suggest that a worryingly high proportion of women are still dying from breast cancer across the world and this seems to correlate strongly with access to breast screening programs and expenditure on healthcare,” said Jönsson.
 
He went on to highlight the distinct lack of accurate and current data in areas like breast cancer incidence and mortality, the economic burden of the disease and detailed patient-linked data on outcomes in relation to treatment patterns and stage of diagnosis. 
 
“This limits analyses of how changes in clinical practice affect patient outcomes and needs to be addressed,” he said.
 
As mortality falls, quality of life is an issue
As breast cancer incidence rates have steadily increased in developed countries over the last 50 years, it is no surprise that the main focus of treatment has been survival. However as more women are now living with the disease, the report suggests that quality of life is becoming a growing issue as survival rates improve. As a result, doctors are urged to focus on measuring the impact of diagnosis and treatment on survivors’ quality of life to identify what problems patients may have and how these can be mitigated.
 
“This report finds a direct link between survival rates in countries and the stage at which breast cancer is diagnosed,” said Goodliffe. “It provides further evidence of the need for early detection and treatment which we welcome given current controversies about the relative harms, benefits and cost effectiveness of breast cancer screening.”
 
Country/continent breakdown: years of healthy life lost/ratio of healthy life lost due to death versus living with disability

Global:                          15,127,050       3.2:1

Africa:                           1,751,772         7.0:1

China:                           1,739,518        2.8:1

United States:               1,294,414        1.6:1

Russia:                              635,497       4.0:1

Germany:                          460,066       1.8:1

Brazil:                                427,393       2.9:1

Japan:                               381,079       2.0:1

France (metropolitan):    352,920        1.5:1

United Kingdom:             340,797        1.8:1

Italy:                                    329,447        1.6:1

Mexico:                               186,906       3.7:1

Spain:                                 171,311       1.8:1

Canada:                              156,963       1.5:1

Turkey:                                151,802       4.4:1

Australia, New Zealand:   113,459       1.5:1

Sweden:                                43,202       1.6:1

Saudi Arabia:                        28,253        4.5:1

 
For more information: newsroom.gehealthcare.com
 
References
[1] Webb, M. L., Cady, B., Michaelson, J. S., Bush, D. M., Calvillo, K. Z., Kopans, D. B. and Smith, B. L. (2013), A failure analysis of invasive breast cancer. Cancer. doi: 10.1002/cncr.2819, and Perry et al European guidelines for quality assurance in breast cancer screening and diagnosis: Fourth Edition http://www.euref.org/european-guidelines

Related Content

Results of Journal of the American College of Surgeons study should reassure breast cancer patients who experienced surgical postponements due to COVID-19 pandemic

Association between Time to Operation and Pathological Stage in DCIS & ER+ Breast Cancer. Courtesy of American College of Surgeons

News | Women's Health | August 07, 2020
August 7, 2020 — A new br...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their annual mammograms now that healthcare facilities across the nation are re-opening their doors following closures due to the COVID-19 pandemic.

Nine-time GRAMMY Award winner and breast cancer survivor Sheryl Crow has served as the spokesperson for Hologic’s Genius 3D Mammography exam for nearly five years.

News | Breast Imaging | August 03, 2020
August 3, 2020 — Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their ann
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State